The global bromelain market size was valued at USD 35.8 million in 2020 and is expected to grow at a CAGR of 7.0% during the forecast period. Bromelain is a cysteine protease obtained from the pineapple plant. The application of bromelain has increased in food and beverages, cosmetics, and dietary supplements owing to its functional benefits. Research suggests that bromelain offers therapeutic benefits in treatment for sinusitis, thrombophlebitis, bronchitis, inflammation, cancer, and surgical trauma. It also eases symptoms associated with cardiovascular disorders, osteoarthritis, and diarrhea.
Know more about this report: request for sample pages
Growing occurrences of health disorders, increasing awareness regarding healthy eating habits, and a rise in health and fitness consciousness are supplementing the market's growth. Consumers are more aware of the advantages of physical exercises and the consumption of functional food products to cater to the body's nutritional requirements. The demand for bromelain has increased during the pandemic owing to its potential to be used in the supportive treatment of COVID-19. Several ongoing research studies analyze bromelain's use as an antiviral against COVID-19 and treat associated symptoms.
Increasing health awareness and growing consumption of dietary supplements to increase immunity positively affect the market. However, the COVID -19 outbreak has disrupted the supply chain across the globe. Limited raw material supply, decreased prices, and limited workforce has severely impacted the market. Countries across the world have regulated the movement of individuals and goods, resulting in reduced deliveries, roadblocks, and other logistic issues.
There has been growth in the use of bromelain in the healthcare sector for the treatment of conditions such as allergies, sinusitis, and colitis, among others. The increasing demand from the meat and seafood sector coupled with the rising consumption of ready-to-cook meals has supplemented the market growth for bromelain. The change in population and growing consumer awareness regarding benefits offered by bromelain has further increased the demand for bromelain. Bromelain-based dietary supplements are increasingly being consumed across the globe owing to their immunity-boosting and anti-inflammation properties.
The market is fueled by the economic growth in countries such as China, Japan, and India, rising disposable income, and changing consumers' lifestyles. Growing awareness regarding skincare and increasing inclination towards the use of natural ingredients has renewed the interest of consumers in bromelain-based cosmetics and personal care products. Bromelain is increasingly being incorporated in dietary supplements owing to its nutritional and biological health benefits. The increasing obese population along with lifestyle changes is expected to drive the market. The sedentary lifestyle of consumers leading to lifestyle diseases, increasing disposable income, growing geriatric population, and growing public initiatives associated with health and wellbeing further aid the market growth.
New product launches and acquisitions by leading players in the market and increasing demand from emerging economies have increased the demand for bromelain-based dietary supplements. In September 2020, Giellepi SpA, a developer of nutraceutical products based in Italy, introduced Bromeyal. Bromeyal is a bromelain ingredient without enteric coating and is derived from pineapple stem. The production involves a proprietary aqueous extraction and multi-step extraction process.
The market is primarily segmented on the basis of source, application, and region.
· North America (U.S., Canada)
· Europe (Germany, UK, France, Italy, Spain, Netherlands, Austria)
· Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia)
· Latin America (Brazil, Mexico, Argentina)
· Middle East & Africa (Saudi Arabia, South Africa, Israel, UAE)
Know more about this report: request for sample pages
On the basis of source, the market is segmented into stem and fruits. There has been a high demand for bromelain extracted from the stem due to its increasing use in the treatment of bronchitis, sinusitis, and surgical traumas. It offers therapeutic benefits, which has increased its application in the healthcare and pharmaceutical sectors. The major factors driving the growth of this segment include the increasing occurrence of lifestyle diseases and rising awareness regarding the health benefits of the product.
The application segment has been divided into healthcare and pharmaceutical, dietary supplements, personal care and cosmetics, food & beverages, and others. The food and beverages segment accounted for a major share of the global bromelain market. Increasing focus on natural and organic products and growing consumption of health-related food and nutritional supplements boost the market growth. Due to its immunity-boosting and anti-inflammation properties, there has been a growing demand for enzyme-based products during the pandemic.
Asia Pacific dominated the global market in 2020. Increasing awareness regarding diet and nutritious eating habits, growing demand from the healthcare sector, and the rising geriatric population are some factors attributed to the growth in this region. The presence of leading market players in the region, increasing disposable income, and changing lifestyles have increased the demand for the enzyme. Growing incidences of health disorders have resulted in increased awareness regarding healthy eating habits, supporting the market growth.
The leading players in the bromelain market include Advanced Enzyme Technologies Limited, Alpspure Lifesciences Private Limited, Antozyme Biotech Pvt Ltd, Biofact India Enterprises, Bio-gen Extracts Private Limited, Biolaxi Corporation, Biozym Gesellschaft für Enzymtechnologie GmbH, Changsha Natureway Co., Ltd., Creative Enzymes, Enzybel International SA, Enzyme Technology (PTY) Ltd., Fooding Group Limited 178, Food State Company 179, Great Food Group of Companies, Guangxi Nanning Javely Biological Products Co., Ltd., Hong Mao Biochemicals Co., Ltd., Krishna Enzytech Pvt. Ltd. 175, Meteoric Biopharmaceuticals Pvt. Ltd., Mitushi Biopharma, Nanning Doing-Higher Bio-Tech Co., Ltd., Nanning Pangbo Biological Engineering Co., Ltd., Nutriteck 176, Senthil Group of Companies, Ursapharm Arzneimittel GmbH, Xena Bio Herbals Pvt. Ltd.
Market size value in 2020
USD 35.8 million
Revenue forecast in 2028
USD 56.5 million
7.0% from 2021 - 2028
2016 - 2019
2021 - 2028
Revenue in USD million and CAGR from 2021 to 2028
By Source, By Application, By Region
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Advanced Enzyme Technologies Limited, Alpspure Lifesciences Private Limited, Antozyme Biotech Pvt Ltd, Biofact India Enterprises, Bio-gen Extracts Private Limited, Biolaxi Corporation, Biozym Gesellschaft für Enzymtechnologie GmbH, Changsha Natureway Co., Ltd., Creative Enzymes, Enzybel International SA, Enzyme Technology (PTY) Ltd., Fooding Group Limited 178, Food State Company 179, Great Food Group of Companies, Guangxi Nanning Javely Biological Products Co., Ltd., Hong Mao Biochemicals Co., Ltd., Krishna Enzytech Pvt. Ltd. 175, Meteoric Biopharmaceuticals Pvt. Ltd., Mitushi Biopharma, Nanning Doing-Higher Bio-Tech Co., Ltd., Nanning Pangbo Biological Engineering Co., Ltd., Nutriteck 176, Senthil Group of Companies, Ursapharm Arzneimittel GmbH, Xena Bio Herbals Pvt. Ltd.